MedTrace Logo

Outcomes Measures in Intellectual Disability

NCT03878251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-06-28

No results posted yet for this study

Summary

Objective quantitative primary endpoints are lacking in Clinical trials in intellectual disability. We propose to develop quantitative interactive attention evaluation criteria in patients with intellectual disability by using games on touchscreen and or eye tracking.

Conditions

  • Attention Deficit in Intellectual Disability

Interventions

DEVICE

Quantitative attention evaluation criteria in intellectual disability

Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)

Sponsors & Collaborators

  • Plateforme PRISME

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • CHARLES Perrine, MD PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-07
Primary Completion
2022-06-07
Completion
2022-06-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03878251 on ClinicalTrials.gov